B. E. Karlberg

841 total citations
52 papers, 677 citations indexed

About

B. E. Karlberg is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, B. E. Karlberg has authored 52 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 19 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Molecular Biology. Recurrent topics in B. E. Karlberg's work include Blood Pressure and Hypertension Studies (11 papers), Hormonal Regulation and Hypertension (10 papers) and Thyroid Disorders and Treatments (5 papers). B. E. Karlberg is often cited by papers focused on Blood Pressure and Hypertension Studies (11 papers), Hormonal Regulation and Hypertension (10 papers) and Thyroid Disorders and Treatments (5 papers). B. E. Karlberg collaborates with scholars based in Sweden, Qatar and United States. B. E. Karlberg's co-authors include Johan Jendle, L. Hansson, H Åberg, K. Peter Öhman, Lennart Tegler, Kerstin Tolagen, L. Weiner, H. von Schenck, Fredrik H. Nyström and Bengt Rosengren and has published in prestigious journals such as Hypertension, European Urology and Clinical Pharmacology & Therapeutics.

In The Last Decade

B. E. Karlberg

51 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. E. Karlberg Sweden 16 286 199 119 106 79 52 677
P Sassano France 15 330 1.2× 242 1.2× 85 0.7× 90 0.8× 117 1.5× 43 647
F LEENEN Canada 14 437 1.5× 185 0.9× 75 0.6× 101 1.0× 71 0.9× 21 682
W F Bremner United Kingdom 15 238 0.8× 155 0.8× 145 1.2× 149 1.4× 128 1.6× 27 817
M Bellet France 13 321 1.1× 112 0.6× 66 0.6× 148 1.4× 92 1.2× 31 574
Z. Glück Switzerland 14 347 1.2× 245 1.2× 96 0.8× 96 0.9× 120 1.5× 24 671
Gerd Bönner Germany 17 470 1.6× 247 1.2× 118 1.0× 121 1.1× 105 1.3× 82 886
A Eisalo Finland 18 393 1.4× 113 0.6× 94 0.8× 117 1.1× 132 1.7× 61 925
Hans J. Keim Germany 11 430 1.5× 194 1.0× 85 0.7× 205 1.9× 105 1.3× 14 728
Lennard Tang Jespersen Denmark 11 258 0.9× 115 0.6× 52 0.4× 66 0.6× 48 0.6× 22 495
J. I. M. Drayer United States 16 781 2.7× 249 1.3× 89 0.7× 72 0.7× 158 2.0× 32 1.1k

Countries citing papers authored by B. E. Karlberg

Since Specialization
Citations

This map shows the geographic impact of B. E. Karlberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. E. Karlberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. E. Karlberg more than expected).

Fields of papers citing papers by B. E. Karlberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. E. Karlberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. E. Karlberg. The network helps show where B. E. Karlberg may publish in the future.

Co-authorship network of co-authors of B. E. Karlberg

This figure shows the co-authorship network connecting the top 25 collaborators of B. E. Karlberg. A scholar is included among the top collaborators of B. E. Karlberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. E. Karlberg. B. E. Karlberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karlberg, B. E., et al.. (1999). Efficacy and safety of telmisartan, a selective AT. Receptor antagonist, compared with enalaprilin elderly patients with primary hypertensions.. Hypertension. 17. 293–302. 1 indexed citations
2.
Jansson, Kjell, Ulf Dahlström, B. E. Karlberg, et al.. (1999). The circulating renin–angiotensin system during treatment with metoprolol or captopril in patients with heart failure due to non‐ischaemic dilated cardiomyopathy. Journal of Internal Medicine. 245(5). 435–443. 13 indexed citations
3.
Öhman, K. Peter & B. E. Karlberg. (1998). Circulating Plasma Prekallikrein and Tissue Kallikrein in Normotensive and Hypertensive Humans: Effects of Angiotensin II Infusion. Clinical and Experimental Hypertension. 20(3). 313–328. 1 indexed citations
4.
5.
Klinge, Petra M., O. Djøseland, B. E. Karlberg, & Christian Hall. (1997). Cardiac secretion of atrial and brain natriuretic peptides in acuteischaemic heart failure in pigs: effect of angiotensin II receptor antagonism. Clinical Physiology. 17(4). 389–400. 4 indexed citations
6.
Nyström, Fredrik H., et al.. (1996). Twenty‐four hour ambulatory blood pressure in the population. Journal of Internal Medicine. 240(5). 279–284. 14 indexed citations
7.
Östergren, Jan, Liv Storstein, B. E. Karlberg, & Gösta Tibblin. (1996). Quality of Life in Hypertensive Patients Treated with Either Carvedilol or Enalapril. Blood Pressure. 5(1). 41–49. 21 indexed citations
8.
Jendle, Johan & B. E. Karlberg. (1996). Effects of intrapulmonary insulin in patients with non-insulin-dependent diabetes. Scandinavian Journal of Clinical and Laboratory Investigation. 56(6). 555–561. 22 indexed citations
9.
Jendle, Johan & B. E. Karlberg. (1996). Intrapulmonary administration of insulin to healthy volunteers. Journal of Internal Medicine. 240(2). 93–98. 34 indexed citations
10.
Jendle, Johan, B. E. Karlberg, & M Arborelius. (1996). An exploration of intrapulmonary insulin administration in anaesthetized and mechanically ventilated pigs. Scandinavian Journal of Clinical and Laboratory Investigation. 56(3). 251–258. 10 indexed citations
11.
Ziedén, Bo, et al.. (1995). Effects of in vitro addition of captopril on copper‐induced low density lipoprotein oxidation.. British Journal of Clinical Pharmacology. 39(2). 201–203. 14 indexed citations
12.
Karlberg, B. E.. (1993). Cough and inhibition of the renin-angiotensin system.. PubMed. 11(3). S49–52. 51 indexed citations
13.
Eggertsen, Robert, et al.. (1993). Effect of coffee on ambulatory blood pressure in patients with treated hypertension. Journal of Internal Medicine. 233(4). 351–355. 23 indexed citations
14.
Agewall, Stefan, et al.. (1991). Reflexogenic neuronal and humoral responses to selective stimulation of low‐pressure cardiopulmonary receptors in man. Journal of Internal Medicine. 229(2). 151–158. 3 indexed citations
15.
Olsson, K., K. Dahlborn, & B. E. Karlberg. (1989). Temporary lack of ANP response to intravenous saline loads in goat kids. Acta Physiologica Scandinavica. 135(4). 591–592. 1 indexed citations
16.
Karlberg, B. E., Robert Larsson, & K. Peter Öhman. (1981). Prizidilol (SKF 92 657) in Primary Hypertension. Clinical Science. 61(s7). 461s–464s. 8 indexed citations
17.
Varenhorst, Eberhard, et al.. (1981). Effects of Oestrogens, Orchidectomy and Cyproterone Acetate on Salt and WaterMetabolism in Carcinoma of the Prostate. European Urology. 7(4). 231–236. 5 indexed citations
18.
Karlberg, B. E., Bertil Kågedal, Lennart Tegler, & Kerstin Tolagen. (1976). Renin concentrations and effects of propranolol and spironolactone in patients with hypertension.. BMJ. 1(6004). 251–254. 25 indexed citations
19.
Hansson, L., et al.. (1975). Controlled study of atenolol in treatment of hypertension.. BMJ. 2(5967). 367–370. 57 indexed citations
20.
Almqvist, Sven & B. E. Karlberg. (1972). [The physiological and clinical effects of TRH, the thyrotropin-releasing hormone].. PubMed. 69(15). 1755–60. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P Sassano Breakdown of academic impact, for papers by F LEENEN Breakdown of academic impact, for papers by W F Bremner Breakdown of academic impact, for papers by M Bellet Breakdown of academic impact, for papers by Z. Glück Breakdown of academic impact, for papers by Gerd Bönner Breakdown of academic impact, for papers by A Eisalo Breakdown of academic impact, for papers by Hans J. Keim Breakdown of academic impact, for papers by Lennard Tang Jespersen Breakdown of academic impact, for papers by J. I. M. Drayer
Rankless by CCL
2026